Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: United Kingdom Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20041
20052
20061
20073
20084
20096
20102
20112
20121
20131
20142
20152
20162
20174
20186
20191
20202
20211
20222
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Terminated4
Active, not recruiting1
Unknown status1
Withdrawn1
Recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S8
AstraZeneca4
MedImmune LLC4
Boehringer Ingelheim3
Eli Lilly and Company3
Hoffmann-La Roche3
Novartis Pharmaceuticals3
Jazz Pharmaceuticals2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
University of Leeds2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 255
Diabetes Mellitus16
Obesity7
Diabetic Nephropathies3
Overweight3
Cardiovascular Diseases2
Dyslipidemias2
Fatty Liver2
Hypertension2
Renal Insufficiency2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.